Teva Pharmaceutical announces new appointments

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced the appointments of Dr. Carlo De Notaristefani as President and Chief Executive Officer of Global Operations, and Mr. Aharon (Arik) Yaari as the Executive Vice President to the newly created organization, Community and Institutional Affairs. Both Dr. De Notaristefani and Mr. Yaari will report directly to Dr. Jeremy Levin, President and Chief Executive Officer of Teva Pharmaceutical Industries and will join the Executive Team.

“We are delighted to have Carlo and Arik in these roles,” said Dr. Levin. “Teva has a long history of commitment to bringing affordable medicines to patients around the world. Through its founding days in Israel the Company has prided itself on the people who have contributed to making Teva a leader in both generic and branded medicines. As part of our strategy, we are committed to recruiting a world class management team from both within the Company and by bringing in international and professional experience from the industry. Teva has a bright future, and I am confident Carlo and Arik will provide critical insight and expertise as the global healthcare market continues to evolve.”

Dr. De Notaristefani will have responsibility for Teva’s product supply and its manufacturing network, and ensure that the Company exceeds the highest standards in executing an integrated supply chain operation on a global level. To accomplish this, and recognizing that Quality Assurance is integral to our success, Dr. De Notaristefani will collaborate closely with Ms. Frances Zipp, Executive Vice President of Quality, who is also a member of the Executive Team, reporting to Dr. Levin. Together, these organizations will work with the goal of making Teva a benchmark of excellence in the industry.

Dr. De Notaristefani has over 25 years of international experience with extensive technical, operational, manufacturing and P&L experience. Recently, Dr. De Notaristefani was at Bristol Myers Squibb (BMS) where he served as President, Technical Operations and Global Support Functions. In this role, he was a member of the company’s senior management team responsible for all manufacturing, technology and capital investments, supply chain, quality and compliance, procurement and information systems strategy and operations. During his tenure at BMS, he led one of the most successful productivity transformations within the pharmaceutical industry. Before joining BMS, Dr. De Notaristefani held several senior positions in manufacturing and supply chain at Aventis Pharmaceuticals. Earlier in his career, he was with Hoechst Marion Roussel, Marion Merrell Dow and Dow Chemical. Dr. De Notaristefani received his doctoral degree in chemical engineering, summa cum laude from University of Naples – Naples, Italy.

“I am extremely proud to join Teva, and to have the opportunity to contribute to the Company’s long tradition of excellence, which was established through its Israeli heritage and today continues as it creates a global organization with a unique combination of innovation, focus and discipline in execution,” stated Dr. De Notaristefani. “We will continue this practice as we begin to set the industry standard for regulatory compliance, customer service and cost effectiveness. I look forward to collaborating with Teva employees to provide unmatched value to patients, customers, and the stakeholders, together with the opportunity to grow the talent within the Company.”

In addition, as part of its strategic objectives, Teva has established an organization of Community and Institutional Affairs. This organization will be led by Mr. Yaari who will execute on Teva’s global commitment to social responsibility, philanthropy, institutional affairs and academic relations. Mr. Yaari will build a cohesive strategy to enhance public well-being by drawing on Teva’s core competencies in developing and manufacturing products to address the unmet needs of patients in all corners of the world.

“In assuming my new role, I am excited about the opportunity to enhance Teva’s involvement in communities around the globe and to expand Teva’s commitment to social responsibility and philanthropy, which is an integral part of the Company’s heritage,” stated Mr. Yaari. “This initiative is a priority for the Company. I look forward to utilizing my global experience and deep personal interest in these efforts to lead our network of collaborations with organizations such as foundations, and academic institutions, as well as with government and international agencies.”

Mr. Yaari joined Teva in 1981, and has served in significant key positions at Teva, such as Group Vice President, Global API, and most recently as Group Vice President, Teva Generics Systems. He has also held various marketing and sales positions, including those in the US and in Kenya and received his B.A. and M.A. in economics (cum laude) from the Hebrew University in 1981 and 1988, respectively.